Advertisement

Archives of Women's Mental Health

, Volume 22, Issue 1, pp 115–118 | Cite as

Obstetric patients’ perspectives on functional magnetic neuroimaging research in pregnant women

  • Rebecca L. Newmark
  • Michelle L. Zaydlin
  • Amy Yang
  • Kelcie Kuchenrither
  • Katherine L. Wisner
  • Suena H. MasseyEmail author
Short Communication

Abstract

Magnetic resonance neuroimaging (MRI) studies of healthy pregnant women could identify key mechanisms of spontaneous health behavior changes observed in expectant mothers as novel intervention targets, but are currently unprecedented. As balancing potential benefits of research with unknown risks, including participant perceptions of risk, is foundational to ethical conduct, we surveyed a convenience obstetric sample to understand pregnant women’s perspectives on this issue. Respondents were 76 pregnant women (modal age of 30–39 years; 64% multiparous) presenting for obstetric care from April to June 2016 at privately and publicly funded clinics at an urban academic medical center in the Midwestern USA. Following a written description about functional magnetic resonance neuroimaging (fMRI) and its known and unknown risks, women were queried on their willingness to participate in a hypothetical study involving fMRI during pregnancy, and specific concerns about doing so, if hesitant or unwilling. Willingness to participate was “yes” (28.4%, n = 21), “maybe” (28.4%, n = 21), and “no” (43.2%, n = 32). Among those responding “maybe” or “no” (n = 53, 73.6%), 11 women (20.7%) articulated concern about the fetus. Other concerns expressed were time commitment (n = 11, 20.7%) and discomfort being in an MRI machine (n = 4; 7.5%). Pregnant women may be open to participating in research involving MRI provided concerns about fetal health, time, and personal comfort are addressed.

Keywords

Pregnancy Plasticity fMRI Neuroimaging Ethics Survey study 

Notes

Acknowledgements

We thank all participants and obstetric staff who made this study possible.

Funding

This study was supported by grant 5K23 DA 037913 from the National Institute on Drug Abuse (NIDA) of the National Institutes of Health (NIH) to Dr. Massey. NIDA and NIH had no role in the study design, data collection, analysis or interpretation of the data, or the decision to submit this work for publication.

Compliance with ethical standards

Conflict of interest

The Department of Psychiatry at Northwestern University receives contractual fees for Dr. Wisner’s consultation to Quinn Emanuel Urquhart and Sullivan, LLP (New York City), who represents Pfizer Pharmaceutical Company. Authors Newmark, Zaydlin, Yang, Kuchenrither, and Massey have no conflicts of interest to report.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

References

  1. Copel J, El-Sayed Y, Heine RP, Wharton KR (2016) Guidelines for diagnostic imaging during pregnancy and lactation. Obstet Gynecol 127:E75–E80CrossRefGoogle Scholar
  2. Corbie-Smith G, Thomas SB, Williams MV, Moody-Ayers S (1999) Attitudes and beliefs of African Americans toward participation in medical research. J Gen Intern Med 14:537–546CrossRefGoogle Scholar
  3. Crozier SR, Robinson SM, Borland SE, Godfrey KM, Cooper C, Inskip HM (2009) Do women change their health behaviours in pregnancy? Findings from the Southampton Women’s Survey. Paediatr Perinat Epidemiol 23:446–453CrossRefGoogle Scholar
  4. Griffiths PD et al (2016) Use of MRI in the diagnosis of fetal brain abnormalities in utero (MERIDIAN): a multicentre. In: Prospective cohort study the lancetGoogle Scholar
  5. Hoekzema E, Barba-Müller E, Pozzobon C, Picado M, Lucco F, García-García D, Soliva JC, Tobeña A, Desco M, Crone EA, Ballesteros A, Carmona S, Vilarroya O (2017) Pregnancy leads to long-lasting changes in human brain structure. Nat Neurosci 20:287–296.  https://doi.org/10.1038/nn.4458 CrossRefPubMedGoogle Scholar
  6. Kendler KS, Ohlsson H, Svikis DS, Sundquist K, Sundquist J (2017) The protective effect of pregnancy on risk for drug abuse: a population, co-relative, co-spouse, and within-individual analysis. Am J Psychiatr 174:954–962CrossRefGoogle Scholar
  7. Kim P, Leckman JF, Mayes LC, Feldman R, Wang X, Swain JE (2010) The plasticity of human maternal brain: longitudinal changes in brain anatomy during the early postpartum period. Behav Neurosci 124:695–700CrossRefGoogle Scholar
  8. Massey SH, Wisner KL (2018) Understanding pregnancy's protective effect on drug use within a developmental framework American Journal of Psychiatry 175(3):286–287Google Scholar
  9. Massey SH, Decety J, Wisner KL, Wakschlag LS (2017) Specification of change mechanisms in pregnant smokers for malleable target identification: a novel approach to a tenacious public health problem. Front Public Health 5:1–12CrossRefGoogle Scholar
  10. Massey SH, Lieberman DZ, Reiss D, Leve LD, Shaw DS, Neiderhiser JM (2011) Association of clinical characteristics and cessation of tobacco, alcohol, and illicit drug use during pregnancy. Am J Addict 20:143–150PubMedGoogle Scholar
  11. Massey SH, Neiderhiser JM, Shaw DS, Leve LD, Ganiban JM, Reiss D (2012) Maternal self concept as a provider and cessation of substance use during pregnancy. Addict Behav 37:956–961CrossRefGoogle Scholar
  12. Ray JG, Vermeulen MJ, Bharatha A, Montanera WJ, Park AL (2016) Association between MRI exposure during pregnancy and fetal and childhood outcomes. JAMA 316:952–961CrossRefGoogle Scholar
  13. Riddle M (2015) News from the NIH (Science of Behavior Change Working Group): using an experimental medicine approach to facilitate translational research. Translational Behavioral Medicine 5:486–488CrossRefGoogle Scholar
  14. Rutherford HJ, Maupin AN, Landi N, Potenza MN, Mayes LC (2017) Current tobacco-smoking and neural responses to infant cues in mothers. Parenting 17:1–10CrossRefGoogle Scholar
  15. Smith YR, Johnson AM, Newman LA, Greene A, Johnson TR, Rogers JL (2007) Perceptions of clinical research participation among African American women. J Women's Health (Larchmt) 16:423–428.  https://doi.org/10.1089/jwh.2006.0124 CrossRefGoogle Scholar
  16. Solomon L, Quinn V (2004) Spontaneous quitting: self-initiated smoking cessation in early pregnancy. Nicotine Tob Res 6(Suppl 2):S203–S216.  https://doi.org/10.1080/14622200410001669132 CrossRefPubMedGoogle Scholar
  17. Sonuga-Barke EJ (2017) Commentary: extraordinary environments, extreme neuroplasticity and mental disorder–reflections on pathways from adversity to mental disorder prompted by McCrory, Gerin, and Viding (2017). J Child Psychol Psychiatry 58:358–360CrossRefGoogle Scholar
  18. Volkow ND (2014) America’s addiction to opioids: heroin and prescription drug abuse Senate Caucus on International Narcotics Control 14Google Scholar
  19. Voos A, Pelphrey K (2013) Functional magnetic resonance imaging. J Cogn Dev 14:1–9CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Austria, part of Springer Nature 2018

Authors and Affiliations

  • Rebecca L. Newmark
    • 1
  • Michelle L. Zaydlin
    • 1
  • Amy Yang
    • 2
  • Kelcie Kuchenrither
    • 1
  • Katherine L. Wisner
    • 1
    • 3
  • Suena H. Massey
    • 1
    • 4
    Email author
  1. 1.Asher Center for the Study and Treatment of Depressive Disorders, Department of Psychiatry and Behavioral SciencesNorthwestern University Feinberg School of MedicineChicagoUSA
  2. 2.Department of Preventive MedicineNorthwestern University Feinberg School of MedicineChicagoUSA
  3. 3.Department of Obstetrics and GynecologyNorthwestern University Feinberg School of MedicineChicagoUSA
  4. 4.Department of Medical Social SciencesNorthwestern University Feinberg School of MedicineChicagoUSA

Personalised recommendations